Erythropoietin - Albumin Platelet-rich Fibrin in Transcrestal Sinus Lifting With Simultaneous Implant Placement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-25

Study Completion Date

2026-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence trans crestal sinus lifting with albumin platelet rich plasma.

Aim of the study: To compare between erythropoietin and albumin platelet rich fibrin transcrestal sinus lifting versus albumin platelet rich fibrin transcrestal sinus lifting using piezoelectric device in patients with atrophic maxilla.

Methods: This study will be carried out as a randomized

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Use of Extended Platelet Rich Fibrin in Lateral Sinus Augmentation

NCT06626776

Sinus Lift Augmentation

NOT_YET_RECRUITING NA

Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting

NCT05831267

Sinus Floor Augmentation Graftless Sinus Elevation

COMPLETED NA

Titanium Platelet-rich Fibrin in Sinus Floor Elevation Through Flapless Transcrestal Approach

NCT05721612

Sinus Floor Elevation

COMPLETED NA

Titanium Prepared Platelet-rich Fibrin in Bone Regeneration in Lateral Window Maxillary Sinus Augmentation

NCT06135077

Sinus Lifting

COMPLETED NA

Posterior Maxillary Ridge Augmentation With Sinus Lift Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft

NCT03014388

Bone Resorption

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sinus Lifting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erythropoietin and albumin PRF gel

Group Type EXPERIMENTAL

Erythropoietin and albumin PRF gel + implant placement

Intervention Type OTHER

This group will be treated by transcrestal sinus lifting with erythropoietin and albumin PRF gel with simultaneous implant placement.

albumin PRF gel

Group Type ACTIVE_COMPARATOR

Albumin PRF gel +implant placement

Intervention Type OTHER

This group (the Control group) will be treated with transcrestal sinus lifting using albumin PRF gel, with simultaneous implant placement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erythropoietin and albumin PRF gel + implant placement

This group will be treated by transcrestal sinus lifting with erythropoietin and albumin PRF gel with simultaneous implant placement.

Intervention Type OTHER

Albumin PRF gel +implant placement

This group (the Control group) will be treated with transcrestal sinus lifting using albumin PRF gel, with simultaneous implant placement.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Residual bone height not less than 5 mm measured from crestal bone to sinus floor.
* Both genders.
* Good oral hygiene
* No previous surgery or radiation treatment on the maxillary sinus

Exclusion Criteria

* Recent radiation therapy in maxilla.
* Uncontrolled systemic diseases such as diabetes mellitus.
* Heavy smoker (those who smoke ≥ 25 cigarettes a day).
* Alcohol abuse.
* Patient on anticoagulant drug
* Severe allergic rhinitis.
* Tumor or large cyst in the maxillary sinus.
* Oroantral fistula.
* Presence of acute or chronic sinus pathoses or sinus membrane perforation.(

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No